Tag Archives: COPD

Keeping Up-to-Date on COPD Controversies: A Clinician Interview

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) aims to increase awareness and research regarding chronic obstructive pulmonary disease (COPD), with the overarching goal of improving COPD prevention, diagnosis, and treatment. The GOLD annual report provides recommendations for COPD management; however, the scientific committee responsible for developing these recommendations notes that there are still… Read More »

Which Drug Combination Works Best to Reduce Acute COPD Exacerbations?

November 20, 2018 Share this content: A higher blood eosinophil count was associated with a greater protective effect of ICS/LABA/LAMA against severe acute COPD exacerbations. A combination of inhaled corticosteroids (ICS)/long-acting β2-agonist (LABA)/long-acting muscarinic receptor antagonist (LAMA) is possibly more effective than a LABA/LAMA combination or single long-acting bronchodilator therapy in reducing the risk for… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that the U.S. Food and Drug Administration (FDA) has approved the  New Drug Application (NDA) for… Read More »